PRTK Annual ROE
37.16%
-9.08%-19.64%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual return on equity is 37.16%, with the most recent change of -9.08% (-19.64%) on December 31, 2022. During the last 3 years, it has risen by +3284.92% (+101.14%).PRTK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly ROE
34.49%
-4.47%-11.47%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly return on equity is 34.49%, with the most recent change of -4.47% (-11.47%) on June 30, 2023. Over the past year, it has dropped by -31.34% (-47.61%).PRTK Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.6% | -47.6% |
| 3 y3 years | +101.1% | -84.5% |
| 5 y5 years | +132.1% | +133.7% |
PRTK ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -65.7% | -94.8% |
Paratek Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | 34.49%(-11.5%) |
| Mar 2023 | - | 38.96%(-3.9%) |
| Dec 2022 | 37.16%(-19.6%) | 40.56%(-33.3%) |
| Sept 2022 | - | 60.77%(-7.7%) |
| June 2022 | - | 65.83%(+32.6%) |
| Mar 2022 | - | 49.66%(-5.2%) |
| Dec 2021 | 46.24%(-51.0%) | 52.39%(+7.5%) |
| Sept 2021 | - | 48.73%(-10.5%) |
| June 2021 | - | 54.43%(-43.1%) |
| Mar 2021 | - | 95.74%(-25.4%) |
| Dec 2020 | 94.41%(-102.9%) | 128.36%(-22.7%) |
| Sept 2020 | - | 166.05%(-25.4%) |
| June 2020 | - | 222.48%(-31.3%) |
| Mar 2020 | - | 323.92%(-51.0%) |
| Dec 2019 | -3247.76%(+1779.7%) | 661.32%(-171.3%) |
| Sept 2019 | - | -927.59%(+189.6%) |
| June 2019 | - | -320.34%(+69.2%) |
| Mar 2019 | - | -189.32%(+29.4%) |
| Dec 2018 | -172.78%(+49.4%) | -146.32%(+14.5%) |
| Sept 2018 | - | -127.75%(+24.8%) |
| June 2018 | - | -102.34%(+12.8%) |
| Mar 2018 | - | -90.73%(-7.9%) |
| Dec 2017 | -115.62%(-10.5%) | -98.50%(-4.2%) |
| Sept 2017 | - | -102.86%(-1.0%) |
| June 2017 | - | -103.89%(-18.9%) |
| Mar 2017 | - | -128.17%(+0.5%) |
| Dec 2016 | -129.18%(+79.1%) | -127.47%(+16.7%) |
| Sept 2016 | - | -109.23%(+11.6%) |
| June 2016 | - | -97.85%(+11.3%) |
| Mar 2016 | - | -87.90%(+34.6%) |
| Dec 2015 | -72.14%(+237.7%) | -65.30%(+16.6%) |
| Sept 2015 | - | -56.00%(+16.9%) |
| June 2015 | - | -47.89%(+21.5%) |
| Mar 2015 | - | -39.41%(+38.1%) |
| Dec 2014 | -21.36%(-35.0%) | -28.54%(-15.7%) |
| Sept 2014 | - | -33.84%(+40.3%) |
| June 2014 | - | -24.12%(-6.4%) |
| Mar 2014 | - | -25.76%(-23.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | -32.84%(+120.3%) | -33.53%(+3.3%) |
| Sept 2013 | - | -32.46%(+57.1%) |
| June 2013 | - | -20.66%(+4.8%) |
| Mar 2013 | - | -19.72%(+37.6%) |
| Dec 2012 | -14.91%(+148.9%) | -14.33%(+6413.6%) |
| Sept 2012 | - | -0.22%(-98.5%) |
| June 2012 | - | -14.67%(+27.2%) |
| Mar 2012 | - | -11.53%(+84.5%) |
| Dec 2011 | -5.99%(-56.6%) | -6.25%(-67.1%) |
| Sept 2011 | - | -19.00%(+27.6%) |
| June 2011 | - | -14.89%(+4.6%) |
| Mar 2011 | - | -14.23%(+3.6%) |
| Dec 2010 | -13.79%(-97.6%) | -13.74%(+6.0%) |
| Sept 2010 | - | -12.96%(-7.7%) |
| June 2010 | - | -14.04%(-30.8%) |
| Mar 2010 | - | -20.28%(-55.5%) |
| Dec 2009 | -582.11%(-1954.4%) | -45.57%(-70.4%) |
| Sept 2009 | - | -153.75%(+3.9%) |
| June 2009 | - | -148.02%(+165.7%) |
| Mar 2009 | - | -55.71%(+16.3%) |
| Dec 2008 | 31.39%(-150.9%) | -47.89%(-183.7%) |
| Sept 2008 | - | 57.20%(-23.6%) |
| June 2008 | - | 74.84%(-245.9%) |
| Mar 2008 | - | -51.28%(-24.7%) |
| Dec 2007 | -61.63%(+24.4%) | -68.12%(-6.2%) |
| Sept 2007 | - | -72.60%(+0.4%) |
| June 2007 | - | -72.33%(-19.5%) |
| Mar 2007 | - | -89.87%(-56.5%) |
| Dec 2006 | -49.53%(-225.8%) | -206.38%(-77.8%) |
| Sept 2006 | - | -928.92%(-733.6%) |
| June 2006 | - | 146.61%(+598.5%) |
| Mar 2006 | - | 20.99%(+6.6%) |
| Dec 2005 | 39.38%(-17.5%) | 19.69%(-29.0%) |
| Sept 2005 | - | 27.75%(+16.3%) |
| June 2005 | - | 23.86%(-53.8%) |
| Mar 2005 | - | 51.62%(+8.2%) |
| Dec 2004 | 47.73%(-41.0%) | 47.73% |
| Dec 2002 | 80.84%(-25.4%) | - |
| Dec 2001 | 108.36% | - |
FAQ
- What is Paratek Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual ROE year-on-year change?
- What is Paratek Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly ROE year-on-year change?
What is Paratek Pharmaceuticals annual return on equity?
The current annual ROE of PRTK is 37.16%
What is the all time high annual ROE for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual return on equity is 108.36%
What is Paratek Pharmaceuticals annual ROE year-on-year change?
Over the past year, PRTK annual return on equity has changed by -9.08% (-19.64%)
What is Paratek Pharmaceuticals quarterly return on equity?
The current quarterly ROE of PRTK is 34.49%
What is the all time high quarterly ROE for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly return on equity is 661.32%
What is Paratek Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, PRTK quarterly return on equity has changed by -31.34% (-47.61%)